EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) major shareholder Cormorant Asset Management, Lp acquired 105,000 shares of the firm’s stock in a transaction dated Tuesday, January 9th. The stock was bought at an average price of $21.32 per share, with a total value of $2,238,600.00. Following the purchase, the insider now directly owns 6,143,235 […]
EyePoint Pharmaceuticals Inc (NASDAQ:EYPT), a specialty pharmaceutical company, focuses on developing and commercializing products for treating eye diseases.
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) has been given an average rating of “Buy” by the six brokerages that are currently covering the firm, Marketbeat.com reports. Six equities research analysts have rated the stock with a buy rating. The average 1-year price objective among analysts that have issued a report on the stock […]